Common Shares Outstanding - Zymeworks Inc (NYSE:ZYME) - Alpha Spread

First Time Loading...

Watchlist Manager

Watchlist

Price: 8.445 USD 0.18%

Updated:

Zymeworks Inc
Common Shares Outstanding

Last Value

3-Years 3-Y CAGR

5-Years 5-Y CAGR

10-Years 10-Y CAGR

Quarterly

Annual

|

Adjust for Inflation

Zymeworks Inc
Common Shares Outstanding Peer Comparison

TH

RPTX

FUSN

AUPH

EDT

Company		Common Shares Outstanding	CAGR 3Y	CAGR 5Y	CAGR 10Y
	Zymeworks Inc NYSE:ZYME	Common Shares Outstanding $70.8m	CAGR 3-Years 15%	CAGR 5-Years 17%	CAGR 10-Years N/A
	Theratechnologies Inc TSX:TH	Common Shares Outstanding $46m	CAGR 3-Years -21%	CAGR 5-Years -10%	CAGR 10-Years -3%
	Repare Therapeutics Inc NASDAQ:RPTX	Common Shares Outstanding $42.2m	CAGR 3-Years 5%	CAGR 5-Years 4%	CAGR 10-Years N/A
	Fusion Pharmaceuticals Inc NASDAQ:FUSN	Common Shares Outstanding $79.7m	CAGR 3-Years 24%	CAGR 5-Years 14%	CAGR 10-Years N/A
	Aurinia Pharmaceuticals Inc NASDAQ:AUPH	Common Shares Outstanding $143.7m	CAGR 3-Years 4%	CAGR 5-Years 9%	CAGR 10-Years 16%
	Spectral Medical Inc TSX:EDT	Common Shares Outstanding CA$279.4m	CAGR 3-Years 5%	CAGR 5-Years 4%	CAGR 10-Years 8%

See Also

Based on the financial report for Dec 31, 2023, Zymeworks Inc's Common Shares Outstanding amounts to 70.8m USD.

Over the last year, the Common Shares Outstanding growth was 10%. The average annual Common Shares Outstanding growth rates for Zymeworks Inc have been 15% over the past three years , 17% over the past five years .

Join more than 142,600+ value investors using Alpha Spread

Create a free account

or see our plans & pricing

About Us Careers Pricing Affiliate Program Terms of Service Privacy Policy

What is Intrinsic Value? Help Center Contact Us

Stock Screener Intrinsic Value Calculator DCF Value Calculator Discount Rate Calculator

Most Undervalued Stocks High Profitability Stocks High Solvency Stocks Most Popular Stocks

© 2024 Alpha Spread Limited. All Rights Reserved.

www.alphaspread.com is not operated by a broker, a dealer, or a registered investment adviser. Under no circumstances does any information posted on www.alphaspread.com represent a recommendation to buy or sell a security. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute, investment advice or recommendations. The information on this site is in no way guaranteed for completeness, accuracy or in any other way. In no event shall Alpha Spread Limited be liable to any member, guest or third party for any damages of any kind arising out of the use of any content or other material published or available on www.alphaspread.com, or relating to the use of, or inability to use, www.alphaspread.com or any content, including, without limitation, any investment losses, lost profits, lost opportunity, special, incidental, indirect, consequential or punitive damages. Past performance is a poor indicator of future performance.